Neo Elite β
1064 nm Nd:YAG laser platform for dermatology and aesthetic applications. [11]
Marketed Β· regulatory scope variesCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Laser platforms for dermatology and aesthetic procedures, including Nd:YAG and Er:YAG systems.
Aerolase develops medical laser systems for dermatology and aesthetic practices. Its Neo portfolio uses 1064 nm Nd:YAG technology, while the Era portfolio uses an ablative 2940 nm Er:YAG platform, addressing different treatment workflows.
The companyβs current portfolio includes Neo Elite and Era Elite branding. A reviewed 2012 FDA decision concerns an earlier named Nd:YAG model family; current model-to-record mapping remains incomplete, so that decision is not presented as blanket clearance for all current products.
Based in Tarrytown, New York, Aerolase combines device development with practitioner education. Historical FDA corrections involving earlier laser models are retained separately from the current portfolio; the two reviewed recall records are terminated.
Aerolase markets the Neo Elite and Era Elite laser platforms. K120235 is a documented Aerolase decision; older LightPod names and the separately manufactured EXCI308 listing require model-specific interpretation rather than extending one clearance to every current platform. [11][5][10][12]
The matched FDA history contains 2 distinct recall events: 0 open, 2 terminated. Z-0768-2020 (2019-08-01; terminated): This relates to the standard 21 CFR 1040.10(f)(3) requiring a readily available remote interlock connector for the laser device Z-1188-2012 (2011-06-07; terminated): It was discovered that customers were not supplied with a procedure and schedule for calibrating the FriendlyLight YAG lasers. [6][7][8]
Latest recorded source review: 2026-10-20.
Documented commercial product families.
1064 nm Nd:YAG laser platform for dermatology and aesthetic applications. [11]
Marketed Β· regulatory scope variesCommercially offered; exact model and country availability should be confirmed with the manufacturer.
2940 nm Er:YAG laser platform for ablative skin procedures. [11]
Marketed Β· regulatory scope variesCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Earlier FriendlyLight and LightPod model families named in FDA records. [11][2]
Commercial availability not establishedLegacy models; current availability and exact lineage require verification.
Selected current laser platforms described; legacy records do not establish current-model clearance coverage. [11]
Accessed 10/20/2026